Stay updated on Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record content, replacing the study details and navigation with an access-denied screen. This blocks access to the essential information the page is intended to present.
    Difference
    17%
    Check dated 2026-09-19T18:46:23.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6, indicating a maintenance update to the study details page. No study content changes are indicated beyond the revision label.
    Difference
    0.0%
    Check dated 2026-08-29T19:36:24.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page transitioned from an error screen to the complete Study Details for NCT05979441, incorporating regulatory information, IPD plans, MeSH terms, study design/outcomes, and the 92 participating locations.
    Difference
    85%
    Check dated 2026-08-15T19:08:39.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, indicating a page update. This change does not modify the study details or displayed information.
    Difference
    0.0%
    Check dated 2026-08-08T14:55:39.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Two new locations were added: Yamaguchi University Hospital in Yamaguchi, Japan, and IRCCS Istituto Clinico Humanitas in Rozzano, Italy, bringing the total number of sites to 92.
    Difference
    0.3%
    Check dated 2026-07-25T10:27:42.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page's revision marker was updated from v3.6.2 to v3.6.3, signaling a new version of the page.
    Difference
    0.0%
    Check dated 2026-07-03T22:41:44.000Z thumbnail image

Stay in the know with updates to Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page.